№66. Cancer immunotherapy

Theme:

Cancer immunotherapy

ТОМ 17, №2, 2016

Download full-text

A history of cancer immunotherapy

DOI 10.31917/1702053

V.M. Moiseyenko, N.M. Volkov
Immunity and cancer

DOI 10.31917/1702062

Z.G. Kadagidze, A.I. Chertkova
Efficacy of immune checkpoints inhibitors in the treatment of solid tumors

DOI 10.31917/1702074

A.A. Rumyantsev, S.A. Tjulandin
Cell-based anticancer immunotherapy methods

DOI 10.31917/1702090

N.M. Volkov
Immunotherapy is based on cytokines (IL-1, IL-2, FNO, CSF, IFN)

DOI 10.31917/1702099

V.A. Chubenko
Immuno-related adverse events of checkpoint inhibitors

DOI 10.31917/1702110

G.Yu. Kharkevich, K.V. Orlova

A history of cancer immunotherapy